Boston CEO

Tue, May 30, 2017
Four Seasons Boston
200 Boylston Street
Boston, MA 02116
(617) 338-4400

Cost: $1950 per person
Dress Code: Business Attire

Boston CEO is a networking forum for industry CEOs and decision makers in the life sciences. Attendees gain insights from presentations and panels featuring CEOs from several of the world's leading biopharmaceutical companies. Industry leaders in venture capital and private equity also participate.

Speakers and co-hosts include: Paul BiondiSVP, Head, BD, Bristol-Myers Squibb; Ron Cooper, President & CEO, Albireo Pharma; Robert Coughlin, President & CEO, Mass Bio; Deborah DunsireCEO, XTuit Pharmaceuticals; Michael Ehlers, EVP, R&D, Biogen; JC Gutierrez-Ramos, CEO, Synlogic Therapeutics; John Haurum, CEO, F-star Biotechnology; Mary Lynne Hedley, Co-Founder, President & COO, TESARO; William Heiden, CEO, AMAG Pharmaceuticals; Ed Kaye, CEO, Sarepta Therapeutics; Jonathan Lewis, CEO, Samus Therapeutics; Martin MackayEVP, Head, R&D, Alexion; John Maraganore, CEO, Alnylam; Geoffrey McDonough, President & CEO, Swedish Orphan Biovitrum; David Meek, CEO, IPSEN; Kia Motesharei, VP, Global Head of BD, Neurology & Immunology, EMD Serono; Francois Nader, Chairman, Acceleron Pharma; Paris Panayiotopoulos, former President & CEO, ARIAD; Adelene Perkins, Chairman & CEO, Infinity Pharmaceuticals; Steven Perrin, CEO & CSO, ALSTDI; Roger Pomerantz, President, CEO & Chairman, Seres Therapeutics; Chandra Ramanathan, VP & Head, East Cost Innovation Center, Bayer; Al Sandrock, CMO & EVP, Neurology Discovery & Development, Biogen; Cynthia Schwalm, EVP of Commercial Operations, North America, IPSEN; Bob Silverman, Head Externalized Drug Discovery Partnering, Roche; Paula Soteropoulos, CEO, Akcea Therapeutics; Roger Tung, CEO, Concert Pharmaceuticals; Sue Washer, President & CEO, AGTC; Christoph Westphal, Co-Founder & Partner, Longwood Fund

 

"Boston CEO is the elite meeting for leaders in biotech. This top notch meeting features unrivaled networking and candid discussions on the most pressing topics facing the industry.” - Henri Termeer, former CEO, Genzyme

"The Boston CEO conference is an invaluable opportunity for CEOs to gather in a casual and off-the-record atmosphere and discuss the most pressing issue in the biotech space and beyond. I look forward to these conferences and fully support their mission to continue to grow Boston’s thriving biopharma community.”John Maraganore, CEO, Alnylam

 

Please call reservations at the Four Seasons today to book your accommodations. Telephone: (617) 338-4400.  Please mention the Boston Biotech Conference rate.

Boston CEO - May 30, 2017 - Four Seasons

Co-hosts: Nessan Bermingham, Paul Biondi, Suzanne Bruhn, Ron Cooper, Robert Coughlin, Deborah Dunsire, Michael Ehlers, Chris Garabedian, JC Gutierrez-Ramos, Mary Lynne Hedley, William Heiden, Ed Kaye, Jay Luly, Martin Mackay, Sandy Macrae, John Maraganore, Geoffrey McDonough, David Meek, Paris Panayiotopoulos, Adelene Perkins, Rob Perez, Roger Pomerantz, Ronald Renaud, Al Sandrock, Paula Soteropoulos, Roger Tung, Sue Washer, Christoph Westphal

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-9:00 am

Welcoming Remarks -- Remembering a Biotech Legend: Henri Termeer
Christoph Westphal
Co-Founder & Partner, Longwood Fund; Rob PerezFounder & Chairman, Life Science Cares; Deborah DunsireCEO, XTuit Pharmaceuticals; Geoffrey McDonoughPresident & CEO, Swedish Orphan Biovitrum; Richard MoscickiDeputy Director, Science Operations, CDER, FDA

9:00-9:20 am

Moderated Keynote
Richard MoscickiDeputy Director, Science Operations, CDER, FDA
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

9:20-9:50 am

CEO Roundtable
Deborah Dunsire, CEO, XTuit Pharmaceuticals; Geoffrey McDonough, President & CEO, Swedish Orphan Biovitrum; Kabir Nath, President & CEO North America Pharmaceuticals, Otsuka America; Rob Perez, Founder & Chairman, Life Science Cares
Moderator: Pierre Jacquet, Managing Director, L.E.K. Consulting

9:50-10:20 am

Healthcare Market Outlook -- 2017 and Beyond
Robert Guidos, Associate Director, Legislative Affairs, CDER, FDA; Jeff Leerink, Chairman & CEO, Leerink Partners; Jessica Richman, CEO, uBiome; Thilo SchroederPartnerNextech Invest; Gary Zieziula, President & Managing Director, EMD Serono
Moderator: Michael Goettler, Global President, Rare Diseases, Pfizer

10:20-10:50 am

Networking Break

10:50-11:20 am

Understanding and Managing Growth
Mary Lynne HedleyCo-Founder, President & COO, TESARO; William Heiden, CEO, AMAG Pharmaceuticals; Sanjiv Patel, CEO, Relay Therapeutics; Shalini Sharp, CFO, Ultragenyx; Timothy Wright, EVP, Strategy, BD, & Innovation, Teva
Moderator: Robert Beardsley, COO, Galera Therapeutics

11:20-11:50 am

Diversity: Moving from Sound Bite to Implementation
Jeff Albers, CEO, Blueprint Medicines; Suzanne Bruhn, President & CEO, Proclara Biosciences; Amri Johnson, Global Head, Diversity & Inclusion, Novartis Institutes for BioMedical Research; Helen Torley, President & CEO, Halozyme Therapeutics
Moderator: Cissy Young, Executive Director, Russell Reynolds

11:50-12:20 pm

Ensuring Transparency and Drug Value
Melissa Bradford-KlugCBO, Keryx; Thomas Lönngrenformer Executive Director, European Medicines Agency; Ed Mascioli, CEO, Karos Pharmaceuticals; Gilmore O'Neill, SVP, Late Stage Clinical Development, Biogen
Moderator: Ron CooperPresident & CEO, Albireo

12:20-1:20 pm

Networking Lunch

1:20-1:50 pm

Accessing Early-Stage Innovation
Ansbert GadickeCo-Founder & Managing Director, MPM Capital; Arthur Krieg, CEO & Founder, Checkmate Pharmaceuticals; Brian McVeighVP, WWBD Transactions & Investment Management, GlaxoSmithKline; Chandra Ramanathan, Head, East Coast Innovation Center, Bayer; Ken Rhodes, CSO, Yumanity
Moderator: Adi HoessCEO, Affimed

1:50-2:20 pm

Therapeutic Market Focus: Microbiome
Rodolphe Clerval, CBO, Enterome; Bernat Olle, CEO, Vedanta Biosciences; Jeff Riley, CEO, Synthetic Biologics; Michele Trucksis, CMO, Seres Therapeutics
Moderator: Todd KruegerPresident, AOBiome

2:20-2:50 pm

Oncology Trends and Predictions
Gil Beyen, Chairman & CEO, Erytech; Roman Fleck, CEO, Janpix; Jimmy Lin, CSO, Natera; Oliver Rosen, CMO, Deciphera; Patrick TricoliCEO, Nanobiotix US
Moderator: Jeremy Goldberg, Managing Director, Torreya Partners

2:50-3:20 pm

Networking Break

3:20-3:50 pm

Building a Biotech: Innovative Business Models
JC Gutierrez-RamosCEO, Synlogic Therapeutics; Ana Maiques, CEO, Neuroelectrics; Eddie Martucci, Co-Founder & CEO, Akili Interactive; Paula Soteropoulos, CEO, Akcea Therapeutics; Gregory VerdineFounder, CEO, & CSO, FogPharma
Moderator: Yuval CohenCEO, Corbus Pharmaceuticals

3:50-4:20 pm

Partner or Go it Alone?
Sharon Clarke, CBO, JDP Therapeutics; Kia MoteshareiGlobal Head, BD, Neurology & Immunology, EMD Serono; Tim Noyes, President & CEO, Proteon Therapeutics; Mark Nuttall, Head, MS & Immunology BD&L, Sanofi Genzyme
Moderator: Chris Casey, Global Head, Key Accounts & Services, Commercial, inVentiv Health

4:20-4:50 pm

Next Generation Biotech CEOs and Board Members
Nessan Bermingham, President & CEO, Intellia Therapeutics; Nancy Lurker, President & CEO, pSivida; Francois Nader, Chairman, Acceleron Pharma; Matt Roden, VP, Strategic Corporate Development, Bristol-Myers Squibb; Leslie Williams, Founder, President & CEO, ImmusanT
Moderator: Robert Forrester, President & CEO, Verastem

4:50-6:00 pm

Cocktails and Hors d'oeuvres

May 31, 2017

Co-hosts: Nessan Bermingham, Paul Biondi, Suzanne Bruhn, Ron Cooper, Robert Coughlin, Deborah Dunsire, Michael Ehlers, Chris Garabedian, JC Gutierrez-Ramos, Mary Lynne Hedley, William Heiden, Ed Kaye, Jay Luly, Martin Mackay, Sandy Macrae, John Maraganore, Geoffrey McDonough, David Meek, Paris Panayiotopoulos, Adelene Perkins, Rob Perez, Roger Pomerantz, Ronald Renaud, Al Sandrock, Paula Soteropoulos, Roger Tung, Sue Washer, Christoph Westphal

Time Agenda
7:30-8:30 am

Registration and Networking Breakfast

8:30-8:40 am

Welcome and Opening Remarks
Roger Tung
, CEO, Concert Pharmaceuticals; Sue Washer, President & CEO, AGTC; Steve Cutler, CEO, ICON; Al Sandrock, CMO & EVP, Biogen

8:40-9:10 am

Advances in Personalized Medicine
Arthur Hiller, CEO, Antyllus; Kenneth Moch, President & CEO, Cognition Therapeutics; Joe Payne, President & CEO, Arcturus; Steven Perrin, CEO & CSO, ALS Therapy Development Institute; Al Sandrock, CMO & EVP, Biogen
Moderator: Robert Silverman, Head, Externalized Drug Discovery PartneringRoche

9:10-9:40 am

Small-Cap and Private Biotech: Leveraging Potential
Frederick Beddingfield
President & CEO, Sienna Biopharmaceuticals; Alan Ezekowitz, CEO, Abide Therapeutics; Brian Leuthner, President & CEO, Edge Therapeutics; Dan Swisher, CEO, Sunesis Pharmaceuticals; Ailis Tweed-Kent, Founder & CEO, Cocoon Biotech
Moderator: Gregg BeloffCFO, Centrexion Therapeutics

9:40-10:10 am

Therapeutic Market Focus: Cell & Gene Therapy
Al Gianchetti
, CEO, XyloCor Therapeutics; Michael JirousekCOO, Frequency Therapeutics; Jak Knowles, President & CEO, Exonics Therapeutics; Sam Rasty, COO, Homology Medicines; Amber Salzman, President & CEO, Adverum Biotechnologies
Moderator: Pascal TouchonSVP, Global Head Strategy & BD&L, Novartis

10:10-10:40 am

Networking Break

10:40-11:00 am

Fireside Chat
Michael Ehlers
EVP, R&D, Biogen; David Meek, CEO, IPSEN
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

11:00-11:30 am

Accessing Innovation via M&A and Partnerships
Sven Dethlefs, Global Head Respiratory Medicines, Teva; Elcin Ergun Barker, President, New Business, EMD Serono; Jeff Jonker, President, NGM Bio; Cynthia Schwalm, President, North America Commercial Operations, IPSEN; Malcolm Weir, CEO, Heptares
Moderator: Sue WasherPresident & CEO, AGTC

11:30-12:00 pm

Buy or Build?
Danguole AltmanPresident & CEO, Vapogenix; Grace Colon, CEO, InCarda Therapeutics; John Cox, CEO, Bioverativ; Roger Tung, CEO, Concert Pharmaceuticals
Moderator: Steve Cutler, CEO, ICON

12:00-1:00 pm

Networking Lunch

1:00-1:30 pm

Evolving BioPharma Boards
James Geraghty, Chairman, Juniper Pharma; Quang Pham, Founder, Chairman & CEO, Espero Pharmaceuticals; Ronald Renaud, CEO, RaNA Therapeutics; David Southwell, President & CEO, Inotek Pharmaceuticals
Moderator: Don deBethizyChairman, Albumedix A/S

1:30-2:00 pm

Boston-Bound Biotech and Pharma: Impact on Innovation
Paul BiondiSVP, Head, BD, Bristol-Myers Squibb; Paul Bolno, President & CEO, WAVE Life Sciences; Chris GarabedianChairman & CEO, Xontogeny; Ole Isacson, Founder, NyaCell; Jonathan Lewis, CEO, Samus Therapeutics
Moderator: Robert Coughlin, President & CEOMassBio

2:00-2:30 pm

Global Markets: Biotechs Across Borders
Carolina Alarco
, President, Global Marketing & International Markets, Aegerion; Samantha Du, Chairperson & CEO, Zai Laboratory; Mark Rothera, CCO, PTC Therapeutics; James Xue, CEO, CANbridge Life Sciences
Moderator: Mary SzelaCEO, Novelion Therapeutics

2:30-3:00 pm

Networking Break

3:00-3:20 pm

Fireside Chat
Robert Coughlin
, President & CEO, MassBio; John Maraganore, CEO, Alnylam
Moderator: Christoph WestphalCo-Founder & Partner, Longwood Fund

3:20-3:50 pm

Achieving Organizational Turnarounds
Richard Daly
, Chairman & CEO, Neuralstem; Ed KayeCEO, Sarepta; Sandy Macrae, CEO, Sangamo Therapeutics; Adelene Perkins, Chairman & CEO, Infinity Pharmaceuticals
Moderator: Hugh Cole, CBO, ARIAD

3:50-4:20 pm

M&A Activity Post the IPO-Boom: Impact on Fundraising and Dealmaking
Luc Dochez, CEO, Tusk Therapeutics; Luba Greenwood, VP, Global BD & M&A, Roche; John HaurumCEO, F-star Biotechnology; Jim Healy, Managing General Partner, Sofinnova Ventures
Moderator: Philippe Lopes-Fernandes, SVP, Global Head, BD & Alliance ManagementEMD Serono

4:20-4:30 pm

Presentation of 2017 Boston CEO Lifetime Achievement Award
Robert Coughlin, 2016 Honoree; John Maraganore, 2015 Honoree

4:30-5:30 pm

Cocktails and Hors d'oeuvres

Hotels

Name Address Phone
Four Seasons Boston 200 Boylston St, Boston, MA (617) 338-4400